Fredrika Svahn

Publications
CV
Public outreach and news

Articles

Article: BRAIN PATHOLOGY. 2021;31(1):61-69

TERT promoter mutations in primary and secondary WHO grade III meningioma.

Maier AD; Stenman A; Svahn F; Mirian C; Bartek J; Juhler M; Zedenius J; Broholm H; Mathiesen T
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2019;43(3):409-421

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.

Stenman A; Svahn F; Hojjat-Farsangi M; Zedenius J; Söderkvist P; Gimm O; Larsson C; Juhlin CC
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2018;42(3):1675-1683

TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.

Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Article: JAMA ONCOLOGY. 2017;3(9):1204-1212

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen J-L; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH; European-American-Asian Pheochromocytoma-Paragangl
Article: GENES CHROMOSOMES & CANCER. 2015;54(9):542-554

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.

Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Article: ENDOCRINE PATHOLOGY. 2015;26(1):9-14

Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.

Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
Article: EPIGENETICS. 2013;8(12):1347-1354

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Bäckdahl M; Höög A; Juhlin CC; Larsson C

All other publications

Thesis / dissertation: 2020

Tumors of the adrenal glands : genetic and diagnostic aspects

Svahn, Fredrika
Letter: CLINICAL ENDOCRINOLOGY. 2018;88(2):343-345

Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma.

Svahn F; Juhlin CC; Paulsson JO; Fotouhi O; Zedenius J; Larsson C; Stenman A
Editorial comment: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2016;39(6):715-716

Absence of the BRAF V600E mutation in pheochromocytoma.

Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
Letter: CLINICAL ENDOCRINOLOGY. 2016;84(4):632-634

Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.

Stenman A; Juhlin CC; Haglund F; Brown TC; Clark VE; Svahn F; Bilguvar K; Goh G; Korah R; Lifton RP; Carling T

Employments

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2021-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2021
Degree Of Master Of Science In Medicine, Karolinska Institutet, 2015

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI